Results 201 to 210 of about 165,940 (211)

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Nature Reviews Cancer, 2019
Jonathan J Havel, Diego Chowell, Timothy A Chan   +2 more
exaly  

Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes

Chemical Society Reviews, 2013
Hui Wei, Erkang Wang
exaly  

Cellulosomes: plant-cell-wall-degrading enzyme complexes

Nature Reviews Microbiology, 2004
Akihiko Kosugi
exaly  

Appraising iniparib, the PARP inhibitor that never was—what must we learn?

Nature Reviews Clinical Oncology, 2013
Joaquin Mateo, Michael Ong, David S P Tan   +2 more
exaly  

Enzyme immobilisation in biocatalysis: why, what and how

Chemical Society Reviews, 2013

exaly  

Enzyme–MOF (metal–organic framework) composites

Chemical Society Reviews, 2017
Xizhen Lian, Yu Fang, Qi Wang
exaly  

Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications

Chemical Reviews, 2019
Yanyan Huang, Jinsong Ren, Xiaogang Qu
exaly  

The evolving landscape of tissue‐agnostic therapies in precision oncology

Ca-A Cancer Journal for Clinicians
Vivek Subbiah, Bettina Ryll, Razelle Kurzrock   +2 more
exaly  

Modifying enzyme activity and selectivity by immobilization

Chemical Society Reviews, 2013
Rafael Costa Rodrigues, Ángel Berenguer-Murcia, Rodrigo Torres   +2 more
exaly  

Heme Enzyme Structure and Function

Chemical Reviews, 2014
Thomas L Poulos
exaly